Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
Clinical trial NCT03558750 · TERMINATED
Trial details
- NCT number
- NCT03558750
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2019-04-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.